RecruitingNCT06749301
Repeatability and Reproducibility of the ADC Map in Head and Neck Cancer. Prospective Multicenter Study
Sponsor
Regina Elena Cancer Institute
Enrollment
150 participants
Start Date
Sep 11, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Evaluation of the repeatability and reproducibility of ADC maps in both primary and non-primary lesions lymph nodes in patients with head and neck cancer, using an acquisition protocol Standardized DWI
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- age over 18 years;
- primary squamous cell carcinoma (SCC) of the hypopharynx, oropharynx, or oral cavity; confirmed by histology;
- a lesion visible on at least three consecutive DWI images, with a minimum diameter of 2 cm;
- specific written informed consent;
Exclusion Criteria3
- incomplete acquisition of DWI images;
- presence of artifacts that do not allow quantitative analysis of DWI images;
- performance status 2 or more according to Zubrod.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06749301
Related Trials
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
NCT066272701 location
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
NCT055269241 location
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
NCT055441366 locations
A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial
NCT072824441 location
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
NCT050759809 locations